Literature DB >> 34530164

A pH-targeted and NIR-responsive NaCl-nanocarrier for photothermal therapy and ion-interference therapy.

Chen Ma1, Yida Zhang2, Yuan Zhang1, Syed Faheem Askari Rizvi3, Guoqing Fu3, Xiaoyan Liu3, Haixia Zhang4.   

Abstract

Transport ions into cells through nanocarrier to achieve ion-interference therapy provides new inspiration for cancer treatment. In this work, a pH-targeted and NIR-responsive NaCl-nanocarrier is prepared using surfactant Vitamin E-O(EG2-Glu) and modified with polydopamine (PDA) and pH-sensitive zwitterionic chitosan (ZWC). The NaCl-nanocarrier is decorated with NH4HCO3 and IR-780 to introduce near-infrared (NIR)-responsive performance and imaging. Once the NaCl-nanocarrier is exposed to NIR laser, the temperature rises rapidly because of the excellent photothermal conversion ability of PDA, then NH4HCO3 is decomposed into NH3 and CO2, which burst the nanocarrier, resulting in Cl- and Na+ "bomb-like" release. This pH-targeted nanocarrier accumulates more at tumor site and when irradiating the site with NIR light, the temperature rises and excessive Cl- and Na+ are released to destroy the ion homeostasis and inhibit tumor growth effectively. Through this strategy, the unique combination of ion interference therapy and photothermal therapy is achieved.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cancer treatment; Ion nanocarriers; Ion-interference therapy; Photothermal therapy

Mesh:

Substances:

Year:  2021        PMID: 34530164     DOI: 10.1016/j.nano.2021.102460

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  1 in total

1.  Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer.

Authors:  Ziyu Meng; Binchao Wang; Yiqiang Liu; Yejian Wan; Qianshi Liu; Huasheng Xu; Renchuan Liang; Ying Shi; Peng Tu; Hong Wu; Chuan Xu
Journal:  Regen Biomater       Date:  2022-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.